期刊论文

Wang, W;Liu, B

英文

NANOMEDICINE

1743-5889

2020

15

7

691-709

10.2217/nnm-2019-0454

This work was partially supported by the Natural Science Foundation of China (81673579 and 81874369), Ministry of Science and Technology (2018YFC1707902 and 2018FY100703), Hunan Department of Science and Technology (2018Wk2081 and 2018SK2110). National Natural Science Foundation of China (No. 81803708). National Natural Science Foundation of Hunan Province (2018JJ3386). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. This work was partially supported by the Natural Science Foundation of China (81673579 and 81874369), Ministry of Science and Technology (2018YFC1707902 and 2018FY100703), Hunan Department of Science and Technology (2018Wk2081 and 2018SK2110). National Natural Science Foundation of China (No. 81803708). National Natural Science Foundation of Hunan Province (2018JJ3386). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

本校为第一且通讯机构

Aim: Development of a new drug-delivery system using a compound derived from Pronephrium penangianum (J5) for the treatment of cervical cancer. Materials & methods: The delivery system was developed using Prussian blue nanoparticles, camouflaged by red blood cell membrane and with folic acid surface modifications. Results: Our results showed the successful development of a nanodrug-delivery system, which increases the half-life and immune evasion ability of the drug. The mechanism of this system was through suppressing B-cell lymphoma 2 and inc...